Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan

<i>Background and Objectives</i>: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system with rising prevalence in the Middle East. Real-world comparative data on disease-modifying therapies from this region remain limited. This retrospective study compared the clinica...

Descripció completa

Dades bibliogràfiques

Autors principals:	Arwa Al Anber, Ola Abu Al Karsaneh, Dua Abuquteish, Osama Abdallah, Mohammad A. Issa, Mohammad Sa’adeh, Dena Kilani
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-01-01
Col·lecció:	Medicina
Matèries:	multiple sclerosis relapsing–remitting MS fingolimod interferon beta-1a annualized relapse rate Jordan
Accés en línia:	https://www.mdpi.com/1648-9144/62/1/203
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!